Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 18, 2024
Estrogen
receptor
positive
(ER
+
)
breast
cancer
is
the
most
common
diagnosed
annually
in
US
with
endocrine-based
therapy
as
standard-of-care
for
this
subtype.
Endocrine
includes
treatment
antiestrogens,
such
selective
estrogen
modulators
(SERMs),
downregulators
(SERDs),
and
aromatase
inhibitors
(AIs).
Despite
appreciable
remission
achievable
these
treatments,
a
substantial
cohort
of
women
will
experience
primary
tumor
recurrence,
subsequent
metastasis,
eventual
death
due
to
their
disease.
In
cases,
cells
have
become
resistant
endocrine
therapy,
resistance
identified
major
obstacle
medical
oncologist
patient.
To
combat
development
resistance,
options
ER
,
HER2
negative
now
include
CDK4/6
used
adjuvants
antiestrogen
treatment.
addition
dysregulated
activity
CDK4/6,
plethora
genetic
biochemical
mechanisms
been
that
contribute
resistance.
These
mechanisms,
which
by
lab-based
studies
utilizing
appropriate
cell
animal
models
cancer,
clinical
gene
expression
profiles
identify
candidate
genes,
are
subject
review.
addition,
we
discuss
molecular
targeting
strategies
utilized
conjunction
or
target
cells.
Of
approaches
currently
being
explored
improve
efficacy
patient
outcome,
two
adaptive
survival
autophagy,
“reversible”
senescence,
considered
targets.
Autophagy
and/or
senescence
induction
response
treatments
often
induced
inhibitors.
Unfortunately,
effective
pathways
not
yet
successfully
developed.
Thus,
there
an
urgent
need
continued
interrogation
autophagy
clinically
relevant
long-term
goal
identifying
new
targets
improved
cancer.
Cells,
Journal Year:
2022,
Volume and Issue:
11(12), P. 1966 - 1966
Published: June 19, 2022
It
is
widely
accepted
that
senescent
cells
accumulate
with
aging.
They
are
characterized
by
replicative
arrest
and
the
release
of
a
myriad
factors
commonly
called
senescence-associated
secretory
phenotype.
Despite
cell
cycle
arrest,
these
metabolically
active
functional.
The
SASP
mostly
thought
to
cause
tissue
dysfunction
induce
senescence
in
surrounding
cells.
As
major
markers
for
aging
senescence,
p16INK4,
p14ARF/p19ARF,
p21
established.
Importantly,
also
implicated
development,
cancer,
homeostasis.
While
many
have
been
identified,
none
able
unambiguously
identify
all
However,
increased
levels
cyclin-dependent
kinase
inhibitors
p16INK4A
often
used
phenotypes.
We
review
here
knowledge
p16INK4A,
embryonic
postnatal
development
potential
functions
pathophysiology
establishment
senolytic
therapies
ultimate
goal
improve
healthy
requires
care
detailed
about
involvement
proteins
developmental
processes
homeostatic
mechanism.
contributes
topics,
summarizes
open
questions,
provides
some
directions
future
research.
Metabolites,
Journal Year:
2023,
Volume and Issue:
13(5), P. 675 - 675
Published: May 21, 2023
The
present
study
aims
to
provide
a
narrative
review
of
the
molecular
mechanisms
Western
diet-induced
obesity
and
obesity-related
carcinogenesis.
A
literature
search
Cochrane
Library,
Embase
Pubmed
databases,
Google
Scholar
grey
was
conducted.
Most
that
induce
are
also
involved
in
twelve
Hallmarks
Cancer,
with
fundamental
process
being
consumption
highly
processed,
energy-dense
diet
deposition
fat
white
adipose
tissue
liver.
generation
crown-like
structures,
macrophages
surrounding
senescent
or
necrotic
adipocytes
hepatocytes,
leads
perpetual
state
chronic
inflammation,
oxidative
stress,
hyperinsulinaemia,
aromatase
activity,
activation
oncogenic
pathways
loss
normal
homeostasis.
Metabolic
reprogramming,
epithelial
mesenchymal
transition,
HIF-1α
signalling,
angiogenesis
host
immune-surveillance
particularly
important.
Obesity-associated
carcinogenesis
is
closely
related
metabolic
syndrome,
hypoxia,
visceral
dysfunction,
oestrogen
synthesis
detrimental
cytokine,
adipokine
exosomal
miRNA
release.
This
important
pathogenesis
oestrogen-sensitive
cancers,
including
breast,
endometrial,
ovarian
thyroid
cancer,
but
‘non-hormonal’
obesity-associated
cancers
such
as
cardio-oesophageal,
colorectal,
renal,
pancreatic,
gallbladder
hepatocellular
adenocarcinoma.
Effective
weight
interventions
may
improve
future
incidence
overall
cancer.
EBioMedicine,
Journal Year:
2023,
Volume and Issue:
94, P. 104717 - 104717
Published: July 11, 2023
Asthma
is
a
heterogeneous
chronic
respiratory
disease
that
impacts
nearly
10%
of
the
population
worldwide.
While
cellular
senescence
normal
physiological
process,
accumulation
senescent
cells
considered
trigger
transforms
physiology
into
pathophysiology
tissue/organ.
Recent
advances
have
suggested
significance
in
asthma.
With
this
review,
we
focus
on
literature
regarding
and
stress
responses
link
triggers
asthma
to
senescence,
including
telomere
shortening,
DNA
damage,
oncogene
activation,
oxidative-related
senescence-associated
secretory
phenotype
(SASP).
The
association
phenotypes,
airway
inflammation
remodeling,
was
also
reviewed.
Importantly,
several
approaches
targeting
such
as
senolytics
senomorphics,
emerged
promising
strategies
for
treatment.
Therefore,
might
represent
mechanism
asthma,
senescence-related
molecules
pathways
could
be
targeted
therapeutic
benefit.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(2), P. 395 - 395
Published: Jan. 6, 2023
New
diagnostic
methods
and
treatments
have
significantly
decreased
the
mortality
rates
of
cancer
patients,
but
further
improvements
are
warranted
based
on
identification
novel
tumor-promoting
molecules
that
can
serve
as
therapeutic
targets.
The
macrophage
migration
inhibitory
factor
(MIF)
family
cytokines,
comprising
MIF
DDT
(also
known
MIF2),
overexpressed
in
almost
all
types,
their
high
expressions
related
to
a
worse
prognosis
for
patients.
is
involved
9
10
hallmarks
cancer,
its
inhibition
by
antibodies,
nanobodies,
or
small
synthetic
has
shown
promising
results.
Even
though
also
proposed
be
several
available
information
about
pro-tumoral
role
mechanism
action
more
limited.
Here,
we
provide
an
overview
involvement
both
propose
blocking
cytokines
needed
obtain
maximum
anti-tumor
response.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(2), P. 470 - 470
Published: Jan. 22, 2024
Melanoma
is
the
third
most
common
type
of
skin
cancer,
characterized
by
its
heterogeneity
and
propensity
to
metastasize
distant
organs.
a
heterogeneous
tumor,
composed
genetically
divergent
subpopulations,
including
small
fraction
melanoma-initiating
cancer
stem-like
cells
(CSCs)
many
non-cancer
stem
(non-CSCs).
CSCs
are
their
unique
surface
proteins
associated
with
aberrant
signaling
pathways
causal
or
consequential
relationship
tumor
progression,
drug
resistance,
recurrence.
Melanomas
also
harbor
significant
alterations
in
functional
genes
(BRAF,
CDKN2A,
NRAS,
TP53,
NF1).
Of
these,
BRAF
NRAS
oncogenes,
50%
melanomas
demonstrating
mutation
(BRAF
MedComm,
Journal Year:
2024,
Volume and Issue:
5(5)
Published: April 24, 2024
Abstract
Aging
exhibits
several
hallmarks
in
common
with
cancer,
such
as
cellular
senescence,
dysbiosis,
inflammation,
genomic
instability,
and
epigenetic
changes.
In
recent
decades,
research
into
the
role
of
senescence
on
tumor
progression
has
received
widespread
attention.
While
how
limits
course
cancer
is
well
established,
also
been
found
to
promote
certain
malignant
phenotypes.
The
tumor‐promoting
effect
mainly
elicited
by
a
senescence‐associated
secretory
phenotype,
which
facilitates
interaction
senescent
cells
their
surroundings.
Targeting
therefore
offers
promising
technique
for
therapy.
Drugs
that
pharmacologically
restore
normal
function
or
eliminate
them
would
assist
reestablishing
homeostasis
cell
signaling.
Here,
we
describe
its
occurrence,
impact
biology.
A
“one‐two‐punch”
therapeutic
strategy
first
induced,
followed
use
senotherapeutics
eliminating
introduced.
advances
application
targeting
treatment
are
outlined,
an
emphasis
drug
categories,
strategies
screening,
design,
efficient
targeting.
This
work
will
foster
thorough
comprehension
encourage
additional
within
this
field.